Conflicts of Interest
CORONAVIRUS INFECTION
D.E.M is an employee and shareholder of TrippBio, Inc. F.S. and R.A.T. are shareholders of TrippBio, Inc. R.A.T. is an inventor on a granted patent application owned by the University of Georgia Research Foundation covering the method of use of probenecid as a treatment for coronavirus infections.